Time trends in atrial fibrillation-related stroke during 2001–2020 in Sweden: a nationwide, observational study
Authors:
Open Access
- 21 February 2023
- journal article
- research article
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 28, 100596
Abstract
No abstract availableKeywords
Funding Information
- Swedish Research Council
- Loo and Hans Osterman Foundation for Medical Research
This publication has 32 references indexed in Scilit:
- Atrial Fibrillation, Stroke Risk, and Warfarin Therapy RevisitedStroke, 2013
- Temporal Trends in Ischemic Stroke and Anticoagulation Therapy Among Medicare Patients With Atrial FibrillationJAMA Internal Medicine, 2013
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillationEuropean Heart Journal, 2012
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine, 2011
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based ApproachChest, 2010
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006Neurology, 2009
- Stroke Severity in Atrial FibrillationStroke, 1996
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991